Xpovio Tablet, Film Coated
Product Images NDC 72237-102

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Xpovio (NDC 72237-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Karyopharm Therapeutics Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Kar00 0023 01)

Chemical structure of selinexor, the active ingredient in XPOVIO. The diagram shows the molecular arrangement including trifluoromethyl groups and heterocyclic rings, consistent with its labeled chemical identity.*

FDA Label Image

Figure (Kar00 0023 02)

A Kaplan-Meier survival curve showing progression-free survival over time (months) in two treatment arms, XvD and Vd. The graph plots survival probability from 0 to 1 against time from 0 to 28 months, with separate survival lines for each arm and the number of subjects at risk tabulated below the x-axis.*

FDA Label Image

Principal Display Panel – 40 mg (once Weekly) Carton Label (Kar00 0023 03)

Packaging label for XPOVIO 40 mg tablets (selinexor), oral film-coated tablets by Karyopharm Therapeutics Inc. The label highlights the dosage as 40 mg once weekly in blister packs, containing 16 film-coated tablets divided into 4 weekly blister packs with each pack holding 4 tablets of 10 mg each. It includes storage instructions and manufacturer information as well as the NDC 72237-106-01.*

FDA Label Image

Principal Display Panel – 40 mg (once Weekly) Blister Sleeve Label (Kar00 0023 04)

Packaging label for XPOVIO (selinexor) 40 mg film-coated tablets in a blister pack containing 4 tablets. The label indicates oral administration with once weekly dosing. Instructions to open the blister pack by pressing and pulling are provided. Manufactured and labeled by Karyopharm Therapeutics Inc. The label includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel – 40 mg (once Weekly) Blister Pack Label (Kar00 0023 05)

Blister pack label for XPOVIO (selinexor) tablets showing a 40 mg dose composed of four 10 mg film-coated oral tablets. The label includes dosage instructions to take only one 40 mg dose per day per week as prescribed, with tablets pushed through foil and swallowed whole with water. Manufactured by Karyopharm Therapeutics Inc.*

FDA Label Image

Principal Display Panel – 80 mg (twice Weekly) Carton Label (Kar00 0023 06)

Packaging label for XPOVIO 80 mg film-coated tablets (selinexor) by Karyopharm Therapeutics Inc. The label indicates blister packs containing 4 individual weekly blister packs, each with 8 tablets (20 mg per tablet) for a total weekly dose of 160 mg. The label includes NDC 72237-101-04 and usage instructions directing to the medication guide. The product is Rx only and manufactured in France.*

FDA Label Image

Principal Display Panel – 80 mg (twice Weekly) Blister Sleeve Label (Kar00 0023 07)

Packaging label for XPOVIO (selinexor) 80 mg oral film-coated tablets in a blister pack containing 8 tablets. The label indicates dosing as 80 mg twice weekly (160 mg total weekly dose). Manufacturer is Karyopharm Therapeutics Inc. The label includes instructions for opening the blister pack and cautions not to break, chew, crush, or divide the tablets.*

FDA Label Image

Principal Display Panel – 80 mg (twice Weekly) Blister Pack Label (Kar00 0023 08)

XPOVIO (selinexor) tablets 80 mg dose in a blister pack with four 20 mg film-coated tablets each. Manufactured by Karyopharm Therapeutics Inc., the label shows instructions to push tablets through foil and swallow whole with water, plus dosage use guidance emphasizing to take one 80 mg dose per day as prescribed.*

FDA Label Image

Principal Display Panel – 40 mg (once Weekly) Carton Label (Kar00 0023 09)

XPOVIO 40 mg film-coated tablets packaging label by Karyopharm Therapeutics Inc. The label indicates the tablets contain selinexor, available in blister packs with four film-coated tablets, each containing 40 mg of selinexor. The medication is intended for once-weekly oral administration. Additional information includes prescription-only status and storage instructions.*

FDA Label Image

Principal Display Panel – 40 mg (once Weekly) Blister Sleeve Label (Kar00 0023 10)

Packaging label for XPOVIO (selinexor) 40 mg film-coated tablets in a blister pack. The label indicates a once-weekly dosage, with instructions to press and hold a button to open the blister. The pack contains one tablet. The labeler is Karyopharm Therapeutics Inc. Additional instructions note not to break, chew, crush, or divide the tablets and refer users to the prescribing information for dosing.*

FDA Label Image

Principal Display Panel – 40 mg (once Weekly) Blister Pack Label (Kar00 0023 11)

Label for XPOVIO (selinexor) 40 mg film-coated tablets from Karyopharm Therapeutics Inc. The label advises taking only one 40 mg dose once per week as prescribed. It includes instructions to push the tablet through the foil and swallow whole with water. The label displays lot and expiration placeholders and manufacturing information from Newton, MA.*

FDA Label Image

Principal Display Panel – 60 mg (once Weekly) Carton Label (Kar00 0023 12)

Packaging label for XPOVIO (selinexor) 60 mg film-coated tablets by Karyopharm Therapeutics Inc. The label indicates the product strength as 60 mg and dosing as once weekly in blister packs. The label displays the NDC code 72237-104-01, packaging details mentioning 4 individual weekly blister packs with each containing one 60 mg tablet, and storage instructions. The product is for prescription use only.*

FDA Label Image

Principal Display Panel – 60 mg (once Weekly) Blister Sleeve Label (Kar00 0023 13)

XPOVIO 60 mg film-coated tablets blister pack by Karyopharm Therapeutics Inc. The pack contains one tablet of selinexor with instructions for weekly oral dosing. Packaging includes directions to press and pull to open and notes not to break, chew, crush, or divide the tablet. The label features the product name, strength, and manufacturer, along with a blue tablet image marked 'X50'.*

FDA Label Image

Principal Display Panel – 60 mg (once Weekly) Blister Pack Label (Kar00 0023 14)

XPOVIO (selinexor) tablets 60 mg dosage label produced by Karyopharm Therapeutics Inc. Instructions emphasize taking only one 60 mg dose once per week as prescribed. The label includes tablet push-through foil instructions and a graphic showing a 60 mg dose tablet blister.*

FDA Label Image

Principal Display Panel – 80 mg (once Weekly) Carton Label (Kar00 0023 15)

Packaging label for XPOVIO (selinexor) tablets, 80 mg strength, presented in blister packs for once weekly oral administration. The label shows the product name, dosage strength, and frequency prominently in yellow and navy sections. It includes labeler information for Karyopharm Therapeutics Inc. and details on packaging format with 4 individual weekly blister packs, each containing 2 tablets of 40 mg strength formulation.*

FDA Label Image

Principal Display Panel – 80 mg (once Weekly) Blister Sleeve Label (Kar00 0023 16)

Packaging label for XPOVIO (selinexor) tablets 80 mg oral film-coated tablets in a blister pack of 2 tablets. The label provides opening instructions for the blister pack and storage information. The product is labeled for prescription use only and manufactured by Karyopharm Therapeutics Inc. The NDC number is 72237-102-12.*

FDA Label Image

Principal Display Panel – 80 mg (once Weekly) Blister Pack Label (Kar00 0023 17)

XPOVIO (selinexor) tablets label showing an 80 mg dose composed of two 40 mg film-coated oral tablets. The label includes dosing instructions emphasizing taking only one 80 mg dose once per week as prescribed. Manufactured for Karyopharm Therapeutics Inc.*

FDA Label Image

Principal Display Panel – 100 mg (once Weekly) Carton Label (Kar00 0023 18)

XPOVIO 100 mg film-coated tablets blister pack label showing the prescription drug name, selinexor as the active ingredient, and dosage strength of 100 mg. The label indicates a dosing schedule of once weekly and contains 4 individual weekly blister packs, each with 2 tablets of 50 mg. Manufactured by Karyopharm Therapeutics Inc., with storage conditions and contact information included on the packaging.*

FDA Label Image

Principal Display Panel – 100 mg (once Weekly) Blister Sleeve Label (Kar00 0023 19)

XPOVIO 100 mg film-coated tablets blister pack for oral use, containing two 50 mg selinexor tablets per blister. The packaging includes instructions for opening by pressing and pulling out the medication card. Manufactured by Karyopharm Therapeutics Inc., the label cautions not to break, chew, crush, or divide the tablets, and advises dispensing a Medication Guide to each patient. The product is Rx only with NDC 72237-103-15.*

FDA Label Image

Principal Display Panel – 100 mg (once Weekly) Blister Pack Label (Kar00 0023 20)

XPOVIO (selinexor) tablets film-coated oral dosage form by Karyopharm Therapeutics Inc. The label shows a 100 mg dose pack consisting of two 50 mg tablets. Instructions emphasize taking only one 100 mg dose per week as prescribed, with tablets pushed through foil and swallowed whole with water.*

FDA Label Image

Principal Display Panel – 80 mg (once Weekly) Carton Label (Kar00 0023 21)

Packaging label for XPOVIO 80 mg (selinexor) film-coated tablets, manufactured by Karyopharm Therapeutics Inc. The label indicates the product is for oral use, prescription only, and supplied in blister packs with 4 individual weekly packs containing one 80 mg tablet each. Storage instructions and manufacturer details are also visible.*

FDA Label Image

Principal Display Panel – 80 mg (once Weekly) Blister Sleeve Label (Kar00 0023 22)

Packaging label for XPOVIO (selinexor) tablets, 80 mg strength, in a blister pack form designed for oral administration. The label indicates a once-weekly dosage with instructions to press and pull out the medication card to open. The labeler is Karyopharm Therapeutics Inc., and the NDC is 72237-105-11.*

FDA Label Image

Principal Display Panel – 80 mg (once Weekly) Blister Pack Label (Kar00 0023 23)

XPOVIO (selinexor) tablets packaging label showing oral film-coated tablets with an 80 mg dose indication. The label instructs to take only one 80 mg dose per week as prescribed, with a note to swallow the tablet whole with water. Manufactured for Karyopharm Therapeutics Inc., Newton, MA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.